[

serum institute of india

]

Latest from serum institute of india

Serum’s Cervavac vaccine for cervical cancer now in pvt hosps

Cervavac vaccine to fight cervical cancer has been developed and manufactured by the Pune-based Serum Institute of India (SII)

FILE PHOTO: A research scientist works inside a laboratory of India's Serum Institute. Cervavac vaccine to fight cervical cancer has been developed and manufactured by the Pune-based Serum Institute of India (SII). (REUTERS (PIC FOR REPRESENTATION))
Updated on Jul 18, 2023 12:54 AM IST
ByVicky Pathare

SII’s multivalent meningococcal meningitis vaccine gets WHO prequalification

It is also the only vaccine that prevents meningitis caused by meningococcal group X, a pathogen increasingly implicated in meningitis outbreaks in Africa

The vaccine protects against meningococcal serogroups A, C, W, Y, and X. (HT file image)
Updated on Jul 12, 2023 06:01 PM IST

RIL tops list of Indian companies, Serum Institute first among unlisted: Report

The Top 10 companies in India hold ₹71.5 lakh crore, accounting for 37% of GDP. 7 of them are headquartered in Mumbai. Here is the list:

Reliance Industries Limited's Mukesh Ambani (Left) and Serum Institute of India's Adar Poonawalla
Published on Jun 20, 2023 05:58 PM IST

HC restrains 2 influencers from posting defamatory content against SII, Covishield

The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.

HT Image
Updated on Jun 06, 2023 01:03 AM IST

Bombay HC restrains activists from posting defamatory content on SII, Covishield

The order was passed in an interim application filed by SII in a defamation suit seeking ₹100 crore in damages from social media influencers Yohan Tengra and Ambar Kori for allegedly posting objectionable content regarding Covishield

Serum Institute of India chief executive officer Adar Poonawalla. (File)
Updated on Jun 05, 2023 03:28 PM IST
Story Saved
Live Score
×
Saved Articles
Following
My Reads
My Offers
Sign out
New Delhi 0C
Tuesday, October 03, 2023
Start 14 Days Free Trial Subscribe Now
Register Free and get Exciting Deals